Antipsychotics – From Blockbuster Brands to Billion Dollar Generics
A report review
This page at Lead Discovery web site reviews an industry report on Second Generation Antipsychotics.
In sum, it says, “Second Generation Antipsychotics (SGAs) continue to drive the antipsychotic market with a growth rate of 27.2% between 2002-2003, yielding revenues of over $9.5 billion in 2003 responsible for a 93.3% share of the market. However, several patent expiries and product launches are set to send the market through a period of change.”
Read more of the report review from here